Email not displaying properly? View email in your browser
Pharmaceutical-Tech

E-Newsletter
Advertise   |    Archives

PROJECTS
GSK
GSK To Invest $139 Million To Expand Production Capacity For BENLYSTA (Belimumab) In Rockville, Maryland

GSK announced $139 million of investment in its biopharmaceutical manufacturing site in Rockville, MD to support growing demand for BENLYSTA® (belimumab) for adult patients with active, autoantibody-positive, systemic lupus erythematosus (SLE) who are receiving standard therapy.The Rockville site is also expected to house production of a new subcutaneous form of belimumab which is currently under review with the FDA. This investment will be used to provide additional... more...

Pall ForteBio
Featured Products
Pamasol Willi Mäder AG
Automatic Indexing Machines
Automatic indexing machines are automatic filling and sealing machines with indexed automatic systems, you can process all commercial containers with the corresponding valves. The machines are adapted to client’s production requirements. Quickly replaceable components guarantee short...

more...

Laboratoria Smeets
Water-Soluble Granules
Labo Smeets (Wilrijk, Belgium) has developed in collaboration with Ghent University a technique to produce water-soluble granules containing poorly water soluble drugs of Class II (poorly soluble, highly permeable) or Class IV (poorly soluble, poorly permeable) of the Bio Classification System (BCS)...

more...

Aurena Laboratories AB
Wound & Skin Care Products
Wound Cleansing And Irrigation Spray In Sterile Saline Solution Helps To Remove Foreign Bodies And Reduces The Number Of Pathogens In A Wound.Medical adhesive remover sprays manufactured from Aurena are formulated using modern no-sting silicones which make the removal of medical adhesives....

more...

 
World Courier
Industry Updates
News
AstraZeneca Sells Migraine Drug For Up To $302 Million
AstraZeneca continued its program of divesting old medicines on Wednesday with the sale for up to $302 million of migraine drug Zomig to Germany's Grunenthal. The British firm, which is betting on new drugs for cancer and other diseases to revive its fortunes, has sold or licensed out a raft..
Press Releases
Promius Pharma Announces Positive Results For Phase 2...
Promius Pharma LLC announced today that its Phase 2 study of the DFN-02, a novel intranasal migraine treatment under clinical development for the acute treatment of adults with migraine with or without aura, met its primary endpoint.In this multicenter, double-blind study...
Events and Exhibitions
18th Annual Drug Discovery Summit
12th June 2017 - 13th June 2017
Oxford Global Marketing Ltd
Germany
Pharma CiMi.CON 2017
26th June 2017- 27th June 2017
We.CONECT Global Leaders
Germany

Subscribe Unsubscribe Advertise Archives
www.pharmaceutical-tech.com - Owned by Ochre Media Pvt. Ltd.
Media Resource Centre, 2nd Floor, Oxford Plaza, Secunderabad - 500 003, Telangana, India
Tel: +91 40 4961 4567 | Fax: +91 40 4961 4555